RecruitingNCT05695222

Cutaneous Squamous Cell Carcinoma Staging Study

Comparison of the Prognostic Capacity of Existing Staging Systems for Cutaneous Squamous Cell Carcinoma


Sponsor

Queen Mary University of London

Enrollment

1,500 participants

Start Date

May 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer, and one of the most common cancers worldwide. The majority of CSCCs are easily removed by surgery and have excellent prognosis. However, a small subset has poor outcomes, including secondary spread in the body (metastasis) and death. The investigators will look at existing CSCC in people from two UK dermatology centres. The investigators will then evaluate the accuracy of current staging systems in predicting risk of poor outcomes in people. The investigators hope that this project will improve the management of patients with CSCC by validating the predictive power of currently available histological staging classifications for cSCC. In the second stage of the study, The investigators will see whether better prediction tools can be found.


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This study aims to improve the staging system used to classify skin squamous cell carcinoma (a common skin cancer) — specifically looking at how accurate the current system is and whether it can be refined using data collected from patients. **You may be eligible if...** - You are over 18 years old - You have been diagnosed with cutaneous squamous cell carcinoma (skin cancer) - You agree for your data to be used for research **You may NOT be eligible if...** - You decline to have your medical data used for research purposes Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERThis is not an interventional study

This is not an interventional study


Locations(2)

Whipps Cross University Hospital

London, United Kingdom

Dr Emilia Peleva

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05695222


Related Trials